Skip to main content

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Signs New Digital Therapeutics Contract with Top-10 PBM

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has inked a new deal with a leading nationwide pharmacy benefits manager (“PBM”), the first contract that has resulted from the company’s strategic partnership with Sanofi U.S. The PBM operates in 50 states, and the agreement notes that the organization will begin the partnership by replacing its existing digital diabetes solution with Dario’s proven cardio metabolic digital therapeutic solution, rolling it out to employer clients beginning Q2 2023. According to the announcement, current members of the PBM’s digital diabetes offering will be transitioned to Dario upon launch; the agreement is expected to generate revenue in the second quarter for the company, with significant growth expected throughout the rest of the year. DRIO is expanding its strategy to include PBMs as it focuses on building strong, diverse partnerships with market-leading healthcare companies. “We are fortunate to have our first PBM partner be with an organization that understands the value of digital therapeutics and has the experience and capabilities to deploy our solutions at scale,” said DarioHealth president Rick Anderson in the press release. “This contract also demonstrates the value of our partnership with Sanofi. After a year of working collaboratively to promote Dario’s solutions to the market, we are excited to see the initial success of those efforts taking shape as the partnership matures.”

To view the full press release, visit

About DarioHealth Corp.

DarioHealth Corp. is a leading digital therapeutics (DTx) company revolutionizing how people with chronic conditions manage their health through a user-centric, multichronic condition platform. Dario’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health. The company’s user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention, and results, and making the right thing to do the easy thing to do. Dario provides its highly user rated solutions globally to health plans and other payors, self-insured employers and providers of care as well as directly to consumers. For more information about the company, please visit

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published:

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office

InvestorWire is part of the InvestorBrandNetwork

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.